Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Kindred Biosciences, Inc. (KIN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Point72 Asset Management, L.P. reports a 0% stake in Kindred Biosciences, Inc.
02/14/2022 SC 13G/A AMERIPRISE FINANCIAL INC reports a 0% stake in Kindred Biosciences, Inc
09/13/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
09/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2021 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in Kindred Biosciences, Inc.
08/30/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 1,709,271 shares @ $9.25, valued at $15.8M
Disposed/sold 2,000 shares @ $9.25, valued at $18.5k
Disposed/sold 400,000 options to buy @ $0.36, valued at $144k
Disposed/sold 350,000 options to buy @ $16.52, valued at $5.8M
Disposed/sold 197,771 options to buy @ $6.46, valued at $1.3M
Disposed/sold 197,771 options to buy @ $3.45, valued at $682.3k
Disposed/sold 175,000 options to buy @ $6.4, valued at $1.1M
Disposed/sold 175,000 options to buy @ $8.75, valued at $1.5M
Disposed/sold 400,000 options to buy @ $9.91, valued at $4M
Disposed/sold 300,000 options to buy @ $9.84, valued at $3M
Disposed/sold 394,000 options to buy @ $4.44, valued at $1.7M
08/30/2021 4 Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 78,613 shares @ $9.25, valued at $727.2k
Disposed/sold 32,500 options to buy @ $6.96, valued at $226.2k
Disposed/sold 10,000 options to buy @ $3.25, valued at $32.5k
Disposed/sold 75,000 options to buy @ $6.4, valued at $480k
Disposed/sold 50,000 options to buy @ $7.1, valued at $355k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 100,000 options to buy @ $9.91, valued at $991k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 83,500 options to buy @ $4.44, valued at $370.7k
08/30/2021 4 Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 145,835 shares @ $9.25, valued at $1.3M
Disposed/sold 20,400 options to buy @ $0.9, valued at $18.4k
Disposed/sold 96,092 options to buy @ $1.37, valued at $131.6k
Disposed/sold 75,000 options to buy @ $15.41, valued at $1.2M
Disposed/sold 59,031 options to buy @ $6.96, valued at $410.9k
Disposed/sold 59,031 options to buy @ $3.45, valued at $203.7k
Disposed/sold 30,000 options to buy @ $3.6, valued at $108k
Disposed/sold 100,000 options to buy @ $6.4, valued at $640k
Disposed/sold 100,000 options to buy @ $8.75, valued at $875k
Disposed/sold 75,000 options to buy @ $12.6, valued at $945k
Disposed/sold 150,000 options to buy @ $9.91, valued at $1.5M
08/30/2021 4 Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 64,306 shares @ $9.25, valued at $594.8k
Disposed/sold 12,000 options to buy @ $19.96, valued at $239.5k
Disposed/sold 7,500 options to buy @ $9.17, valued at $68.8k
Disposed/sold 8,000 options to buy @ $6.96, valued at $55.7k
Disposed/sold 10,000 options to buy @ $3.25, valued at $32.5k
Disposed/sold 15,000 options to buy @ $3.6, valued at $54k
Disposed/sold 75,000 options to buy @ $6.4, valued at $480k
Disposed/sold 50,000 options to buy @ $7.65, valued at $382.5k
Disposed/sold 80,000 options to buy @ $8.75, valued at $700k
Disposed/sold 100,000 options to buy @ $9.91, valued at $991k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
08/30/2021 4 Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 40,000 options to buy @ $0.32, valued at $12.8k
Disposed/sold 20,000 options to buy @ $1.37, valued at $27.4k
Disposed/sold 35,000 options to buy @ $15.41, valued at $539.4k
Disposed/sold 44,000 options to buy @ $6.96, valued at $306.2k
Disposed/sold 44,000 options to buy @ $3.45, valued at $151.8k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 50,000 options to buy @ $9.91, valued at $495.5k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 50,000 options to buy @ $4.44, valued at $222k
08/30/2021 4 Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 24,928 shares @ $9.25, valued at $230.6k
Disposed/sold 20,000 options to buy @ $7, valued at $140k
Disposed/sold 34,000 options to buy @ $15.41, valued at $523.9k
Disposed/sold 44,000 options to buy @ $6.96, valued at $306.2k
Disposed/sold 18,892 options to buy @ $3.45, valued at $65.2k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 50,000 options to buy @ $9.91, valued at $495.5k
Disposed/sold 50,000 options to buy @ $9.84, valued at $492k
Disposed/sold 50,000 options to buy @ $4.44, valued at $222k
08/30/2021 4 MONTGOMERY HERBERT D (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 27,500 options to buy @ $3.52, valued at $96.8k
Disposed/sold 3,350 options to buy @ $4.14, valued at $13.9k
Disposed/sold 49,900 options to buy @ $6.4, valued at $319.4k
Disposed/sold 75,000 options to buy @ $8.75, valued at $656.3k
Disposed/sold 51,500 options to buy @ $9.91, valued at $510.4k
Disposed/sold 51,500 options to buy @ $9.84, valued at $506.8k
Disposed/sold 51,500 options to buy @ $4.44, valued at $228.7k
08/30/2021 4 McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 41,890 options to buy @ $9.65, valued at $404.2k
Disposed/sold 10,000 options to buy @ $11, valued at $110k
Disposed/sold 48,500 options to buy @ $9.91, valued at $480.6k
Disposed/sold 48,500 options to buy @ $9.84, valued at $477.2k
Disposed/sold 48,500 options to buy @ $4.44, valued at $215.3k
08/30/2021 4 Lien Lyndon (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 47,000 options to buy @ $5.08, valued at $238.8k
08/30/2021 4 Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Disposed/sold 48,000 options to buy @ $5.08, valued at $243.8k
08/30/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/30/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/30/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/30/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/30/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/30/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/30/2021 4 Elanco Animal Health Inc (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Bought 45,508,938 shares @ $9.25, valued at $421M
08/30/2021 8-K Quarterly results
08/30/2021 SC 13D/A Elanco Animal Health Inc reports a 100% stake in Kindred Biosciences, Inc.
08/27/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/26/2021 8-K Quarterly results
08/09/2021 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
08/09/2021 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
08/05/2021 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 4.4% stake in Kindred Biosciences, Inc.
08/05/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/04/2021 4 Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.
Txns: Gifted 320,000 shares @ $0
Sold 40,000 shares @ $9.206, valued at $368.2k
08/02/2021 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy